{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:53:35Z","timestamp":1790146415882,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.cca.2017.05.029","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T07:01:20Z","timestamp":1495522880000},"page":"119-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Performance of ROMA based on Architect CA 125 II and HE4 values in Chinese women presenting with a pelvic mass: A multicenter prospective study"],"prefix":"10.1016","volume":"471","author":[{"given":"Fengxian","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2017.05.029_bb0005","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1006\/gyno.1994.1340","article-title":"Management of the adnexal mass","volume":"55","author":"Curtin","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2017.05.029_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1074\/mcp.R400006-MCP200","article-title":"Progress and challenges in screening for early detection of ovarian cancer","volume":"3","author":"Jacobs","year":"2004","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.cca.2017.05.029_bb0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/gyno.2001.6460","article-title":"A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?","volume":"84","author":"Carney","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2017.05.029_bb0020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.21616","article-title":"Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma","volume":"106","author":"Engelen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.cca.2017.05.029_bb0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2009.12.033","article-title":"Quality of care in advanced ovarian cancer: the importance of provider specialty","volume":"117","author":"Mercado","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2017.05.029_bb0030","first-page":"703","article-title":"CA125 antigen levels in obstetric and gynecologic patients","volume":"64","author":"Niloff","year":"1984","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.cca.2017.05.029_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.humrep.a136832","article-title":"The CA 125 tumour-associated antigen: a review of the literature","volume":"4","author":"Jacobs","year":"1989","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.cca.2017.05.029_bb0040","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/clinchem\/37.8.1379","article-title":"Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases","volume":"37","author":"Molina","year":"1991","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2017.05.029_bb0045","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000181180","article-title":"Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE","volume":"29","author":"Molina","year":"2008","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cca.2017.05.029_bb0050","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","article-title":"A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer","volume":"97","author":"Jacobs","year":"1990","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.cca.2017.05.029_bb0055","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/AOG.0b013e318195ad17","article-title":"The accuracy of risk scores in predicting ovarian malignancy: a systematic review","volume":"113","author":"Geomini","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.cca.2017.05.029_bb0060","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstrom","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.cca.2017.05.029_bb0065","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.cca.2017.05.029_bb0070","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2017.05.029_bb0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2017.05.029_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.03.043","article-title":"Comparison of a novel multiple marker assay vs the risk of malignancy index for the prediction of epithelial ovarian cancer in patients with a pelvic mass","volume":"203","author":"Moore","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.cca.2017.05.029_bb0085","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.ejca.2011.12.003","article-title":"Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses","volume":"48","author":"Van Gorp","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cca.2017.05.029_bb0090","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/AOG.0b013e31821b5118","article-title":"Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors","volume":"117","author":"Ueland","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.cca.2017.05.029_bb0095","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/AOG.0b013e31821b1d80","article-title":"Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay","volume":"117","author":"Ware Miller","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.cca.2017.05.029_bb0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3892\/br.2016.682","article-title":"The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer","volume":"5","author":"Su","year":"2016","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.cca.2017.05.029_bb0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000446238","article-title":"Is the risk of ovarian malignancy algorithm better than other tests for predicting ovarian malignancy in women with pelvic masses?","volume":"82","author":"Yanaranop","year":"2017","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.cca.2017.05.029_bb0110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2016.01.016","article-title":"HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: an Italian multicenter study","volume":"141","author":"Romagnolo","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2017.05.029_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cca.2014.11.013","article-title":"Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses","volume":"440","author":"Chen","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2017.05.029_bb0120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/1471-2407-13-423","article-title":"Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses","volume":"13","author":"Pitta 1","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cca.2017.05.029_bb0125","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/IGC.0000000000000804","article-title":"Diagnostic performance of risk of ovarian malignancy algorithm against CA125 and HE4 in connection with ovarian cancer: a meta-analysis","volume":"26","author":"Dayyani","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.cca.2017.05.029_bb0130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.6061\/clinics\/2012(05)06","article-title":"A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses","volume":"67","author":"Anton","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.cca.2017.05.029_bb0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2012.09.034","article-title":"The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass","volume":"128","author":"Chan","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2017.05.029_bb0140","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","article-title":"HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the risk of ovarian malignancy algorithm","volume":"104","author":"Van Gorp","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cca.2017.05.029_bb0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2016.01.016","article-title":"HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: an Italian multicenter study","volume":"141","author":"Romagnolo","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2017.05.029_bb0150","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cca.2016.06.010","article-title":"Value of serum human epididymis secretory protein 4 as a marker for differential diagnosis of malignant and benign gynecological diseases of patients in southern China","volume":"459","author":"Li","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2017.05.029_bb0155","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3346\/jkms.2015.30.12.1777","article-title":"Comparison of HE4, CA125, and risk of ovarian malignancy algorithm in the prediction of ovarian cancer in Korean women","volume":"30","author":"Cho","year":"2015","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.cca.2017.05.029_bb0160","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/01.AOG.0000267198.25223.bc","article-title":"How relevant are ACOG and SGO guidelines for referral of adnexal mass?","volume":"110","author":"Dearking","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.cca.2017.05.029_bb0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/gyno.2002.6865","volume":"87","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2017.05.029_bb0170","unstructured":"Architect ROMA e-Assay File. www.abbottdiagnostics.com."},{"key":"10.1016\/j.cca.2017.05.029_bb0175","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.cca.2017.05.029_bb0180","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1471-2407-12-258","article-title":"Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis","volume":"12","author":"Li","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cca.2017.05.029_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.12.029","article-title":"Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders","volume":"206","author":"Moore","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.cca.2017.05.029_bb0190","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1158\/1078-0432.CCR-03-0409","article-title":"Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis","volume":"10","author":"Lu","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cca.2017.05.029_bb0195","first-page":"457","article-title":"Diagnostic performances of CA125, HE4, and ROMA index in ovarian cancer","volume":"36","author":"Dikmen","year":"2015","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.cca.2017.05.029_bb0200","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/ijc.26129","article-title":"Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer","volume":"130","author":"Park","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cca.2017.05.029_bb0205","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.clinbiochem.2013.08.019","article-title":"The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay","volume":"46","author":"Yang","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2017.05.029_bb0210","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1515\/CCLM.2011.709","article-title":"The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses","volume":"49","author":"Lenhard","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2017.05.029_bb0215","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s13277-011-0204-3","article-title":"HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases","volume":"32","author":"Molina","year":"2011","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cca.2017.05.029_bb0220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cca.2015.03.047","article-title":"HE4 in the differential diagnosis of ovarian masses","volume":"446","author":"Granato","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2017.05.029_bb0225","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/IGC.0000000000000442","article-title":"Effectiveness of the risk of malignancy index and the risk of ovarian malignancy algorithm in a cohort of women with ovarian cancer: does histotype and stage matter?","volume":"25","author":"Lennox","year":"2015","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117302188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117302188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T07:44:19Z","timestamp":1602143059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898117302188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":45,"alternative-id":["S0009898117302188"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2017.05.029","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of ROMA based on Architect CA 125 II and HE4 values in Chinese women presenting with a pelvic mass: A multicenter prospective study","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2017.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}